These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29134827)

  • 61. The potential of circulating cell free RNA as a biomarker in cancer.
    Cheung KWE; Choi SR; Lee LTC; Lee NLE; Tsang HF; Cheng YT; Cho WCS; Wong EYL; Wong SCC
    Expert Rev Mol Diagn; 2019 Jul; 19(7):579-590. PubMed ID: 31215265
    [No Abstract]   [Full Text] [Related]  

  • 62. Micro-RNA Profiling as a Predictor of Clinical Outcomes for Head and Neck Cancer Patients.
    Isayeva T; Brandwein-Gensler M; Somarathna M; Moore-Smith LD; Lee T
    Curr Pharm Des; 2017; 23(32):4729-4744. PubMed ID: 28571552
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Detection, prediction, and prognosis: blood circulating microRNA as novel molecular markers of head and neck cancer patients.
    Powrózek T; Porgador A; Małecka-Massalska T
    Expert Rev Mol Diagn; 2020 Jan; 20(1):31-39. PubMed ID: 31778325
    [No Abstract]   [Full Text] [Related]  

  • 64. Application of salivary noncoding microRNAs for the diagnosis of oral cancers.
    Deutsch FT; Khoury SJ; Sunwoo JB; Elliott MS; Tran NT
    Head Neck; 2020 Oct; 42(10):3072-3083. PubMed ID: 32686879
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effective early detection of oral cancer using a simple and inexpensive point of care device in oral rinses.
    Franzmann EJ; Donovan MJ
    Expert Rev Mol Diagn; 2018 Oct; 18(10):837-844. PubMed ID: 30221559
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Circulating microRNAs in head and neck cancer: a scoping review of methods.
    Dharmawardana N; Ooi EH; Woods C; Hussey D
    Clin Exp Metastasis; 2019 Jun; 36(3):291-302. PubMed ID: 30877500
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Liquid biopsy: the value of different bodily fluids.
    Santos V; Freitas C; Fernandes MG; Sousa C; Reboredo C; Cruz-Martins N; Mosquera J; Hespanhol V; Campelo R
    Biomark Med; 2022 Feb; 16(2):127-145. PubMed ID: 35073730
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Head and neck cancer biomarkers: Systematic review and meta-analysis.
    Marakala V
    Clin Chim Acta; 2023 Mar; 542():117280. PubMed ID: 36878379
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Saliva Based Liquid Biopsies in Head and Neck Cancer: How Far Are We From the Clinic?
    Patel A; Patel S; Patel P; Tanavde V
    Front Oncol; 2022; 12():828434. PubMed ID: 35387114
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Urinary microRNA and mRNA in Tumors.
    Bandini E
    Methods Mol Biol; 2021; 2292():57-72. PubMed ID: 33651352
    [TBL] [Abstract][Full Text] [Related]  

  • 71. What to look for in cell-free DNA from breast cancer patients.
    Bronte G; Ravaioli S; Bravaccini S
    Breast Cancer Res Treat; 2018 Jul; 170(1):199-200. PubMed ID: 29480448
    [No Abstract]   [Full Text] [Related]  

  • 72. What every dentist needs to know about liquid biopsies.
    Bosshard SL; Hackett CL; Brooks JK; Bashirelahi N
    Gen Dent; 2019; 67(2):31-33. PubMed ID: 30875304
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Non-Invasive microRNA Profiling in Saliva can Serve as a Biomarker of Alcohol Exposure and Its Effects in Humans.
    Mead EA; Boulghassoul-Pietrzykowska N; Wang Y; Anees O; Kinstlinger NS; Lee M; Hamza S; Feng Y; Pietrzykowski AZ
    Front Genet; 2021; 12():804222. PubMed ID: 35126468
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Circulating tumor DNA in the saliva of patients with head and neck cancer: A pilot report.
    Lee YC; Kim SI; Kwon H; Bae JS; Lee S
    Oral Dis; 2021 Sep; 27(6):1421-1425. PubMed ID: 33073423
    [No Abstract]   [Full Text] [Related]  

  • 75. Early detection and personalized treatment in oral cancer: the impact of omics approaches.
    Ribeiro IP; Barroso L; Marques F; Melo JB; Carreira IM
    Mol Cytogenet; 2016; 9():85. PubMed ID: 27895714
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An appraisal of pivotal evaluation designs in validating noninvasive biomarkers for head and neck cancer detection.
    Adeoye J; Wan CCJ; Thomson P
    Acta Oncol; 2020 Dec; 59(12):1500-1502. PubMed ID: 32924723
    [No Abstract]   [Full Text] [Related]  

  • 77. Salivary biomarkers for oral cancer and pre-cancer screening: a review.
    Kaur J; Jacobs R; Huang Y; Salvo N; Politis C
    Clin Oral Investig; 2018 Mar; 22(2):633-640. PubMed ID: 29344805
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of Salivary Biomarkers in Oral Cancer Detection.
    Khurshid Z; Zafar MS; Khan RS; Najeeb S; Slowey PD; Rehman IU
    Adv Clin Chem; 2018; 86():23-70. PubMed ID: 30144841
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cell-free nucleic acids in body fluids as biomarkers for the prediction and early detection of recurrent head and neck cancer: A systematic review of the literature.
    van Ginkel JH; Slieker FJB; de Bree R; van Es RJJ; Van Cann EM; Willems SM
    Oral Oncol; 2017 Dec; 75():8-15. PubMed ID: 29224828
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Liquid Biopsy in Head and Neck Cancer: Promises and Challenges.
    Nonaka T; Wong DTW
    J Dent Res; 2018 Jun; 97(6):701-708. PubMed ID: 29513618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.